FDA Investigator Abby E Pelletier
Abby E Pelletier has conducted inspections on 177 sites in 4 countries as of 21 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
177
Last Inspection Date:
21 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
India,
Canada,
Puerto Rico
FDA Investigators that have inspected at least one site in common with Abby E Pelletier:
Aaron L Morris,
Alan R Condon,
Alfred P Pistorio,
Alice C Silva,
Allison A Rodriguez,
Almaris N Alonso,
Alois P Provost,
Althea A Williams,
Alysia M Salonia,
Alyssa R Favro,
Amber G Wardwell,
Amy C Jordan,
Andrew M Barlow,
Angela J Davis,
Ann L Demarco,
Anthony J Ladner,
Anthony N Onianwa,
Anthony W Thomas,
Arsen Karapetyan,
Ashley M Whitehurst,
Atricia L Irons,
Azza Talaat,
Bradford L Swanson,
Brandy L Couillard,
Brandy L Gillilan,
Brenda P King,
Brian R Sweeney,
Brian R Yaun,
Camerson E Moore,
Carl A Huffman, III,
Carla C Tuite,
Christopher A Demitrius,
Christopher K Vantwuyver,
Christopher M Elliott,
Clinton V Giustra,
Concepcion Cruz, Jr,
Constance Desimone,
Daniel J Roberts,
Darin S Wiegers,
David A Oluwo,
David C Sullivan,
David J Feria,
David P Vanhouten,
Dawn M Braswell,
Dean R Rugnetta,
Debra I Love,
Dianiris C Ayala,
Dolores Harper,
Dominic R Frasca,
Dorothy W Lee,
Douglas S Joslin,
Dr. Barbara D Paul, PhD,
Dr. Gang Wang, PhD,
Eileen A Liu,
Eileen T Maher,
Elise L Mcdevitt,
Elizabeth B Griffin,
Ellen P Madigan,
Emily J Schramm,
Emir Galevi,
Eric C Schmitt,
Erica B Raphael,
Garry H Stewart,
Gary J Hagan,
George T Allen, Jr,
Gerard D Difiore,
Guozhou Mo,
Jacqueline Mdiaz Albertini,
James P Finn,
James W Whitney,
Jamie S Mathews,
Jason A Rossi,
Jeffrey J Thibodeau,
John A Hamilton, III,
John A Sciacchitano,
John L Zaccone,
John P Mistler,
John P Shelton,
John R Carlson,
John S Hartford,
Jonathan B Lewis,
Jonathan G Matrisciano,
Joseph B Cascio,
Joseph H Procopio, Jr,
Joseph T Frost,
Joyce A Kellett,
Juan Rjimenez Garcia,
Justin A Boyd,
Justine M Corson,
Karen L Kosar,
Katarzyna Plona,
Kathleen E Mcafoose,
Kenneth H Williams,
Kent A Conforti,
Kevin P Foley,
Kwong P Lee,
Laiza V Garcia,
Lauren M Lawrance,
Lauren M Mclaughlin,
Laurie B Frazier,
LCDR Debra Emerson,
Lisa M Ayer,
Logan T Williams,
Louis Christy,
LT Luis O Rodriguez,
Lucila B Nwatu,
Lyndsay M Perryman,
Lynne M Dwyer,
Marcia M Laughrey,
Margaret E Walsh,
Margaret M Sands,
Mark E Farrell,
Mark K Tseng,
Mark R Mcclain,
Martin J Guardia,
Mary Jeanet Mcgarry,
Maryam Tabatabaie,
Matthew B Casale,
Matthew C Watson,
Matthew D Silverman,
Matthew W Kyle,
Maura Rooney,
Maureen L Dreher,
Megan A Haggerty,
Michael G Mayfield,
Michael J Leal,
Michael J Pasternak,
Michael L Casner,
Michael P Sweeney,
Michelle M Noe Varga,
Mutahar S Shamsi,
Nabil Nakhoul,
Nadia R Barreda,
Narong Chamkasem, PhD,
Nassim Ben Makhlouf,
Nathan B Davis,
Neil J Bonzagni, PhD MPH,
Nichole B Murphy,
Nydia E Colon,
Pamela L Ogonowski,
Paraluman S Leonin,
Paul E Stein,
Paul P Geraci,
Paula M Laplant,
Philip H Lafleur,
Preston M Lee,
Qiao Y Bobo,
Rafeeq A Habeeb,
Rebecca A Coleman,
Richard F Hapke,
Richard K Vogel,
Richard L Licari,
Rita K Kabaso,
Rita K Vick,
Robert J Martin,
Robert O'brian,
Ronald T Weber,
Rory K Geyer,
Rupa Pradhan,
Sandra P White,
Sangeeta M Khurana, PhD,
Sangeeta M Rataul,
Sara M Onyango,
Sara M Richardson,
Scott M Loughan,
Sean M Tessicini,
Sean R Marcsisin,
Seth A Mailhot,
Shawn M Bogdan,
Sherry K Markwell,
Slater K Bartlett,
Stacey S Degarmo,
Stephen C King,
Stephen C Smith,
Stephen D Brown,
Stephen R Souza,
Steven P Donald,
Sunita Pandey,
Susanne M Richardson, MS RAC,
Suzanne M Healy,
Tamara S Rosbury,
Tania K Mercado,
Teddy Tom,
Terry C Kimball,
Thomas J Arista,
Thomas O Morgan,
Todd J Maushart,
Tonia F Bernard,
Torrance J Slayton,
Troy R Petrillo,
Unnee Ranjan,
Vilmary Negron Rodriguez,
Wanda J Torres,
Yasamin Ameri
Abby E Pelletier's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more